• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卟啉脂蛋白积累和卟啉脂蛋白光动力疗法对癌细胞特异性细胞毒性的影响。

Porphylipoprotein Accumulation and Porphylipoprotein Photodynamic Therapy Effects Involving Cancer Cell-Specific Cytotoxicity.

机构信息

Faculty of Medicine, University of Tsukuba, Ibaraki 305-8577, Japan.

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.

出版信息

Int J Mol Sci. 2021 Jul 7;22(14):7306. doi: 10.3390/ijms22147306.

DOI:10.3390/ijms22147306
PMID:34298933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8305091/
Abstract

In photodynamic therapy (PDT) for neoplasms, photosensitizers selectively accumulate in cancer tissue. Upon excitation with light of an optimal wavelength, the photosensitizer and surrounding molecules generate reactive oxygen species, resulting in cancer cell-specific cytotoxicity. Porphylipoprotein (PLP) has a porphyrin-based nanostructure. The porphyrin moiety of PLP is quenched because of its structure. When PLP is disrupted, the stacked porphyrins are separated into single molecules and act as photosensitizers. Unless PLP is disrupted, there is no photosensitive disorder in normal tissues. PLP can attenuate the photosensitive disorder compared with other photosensitizers and is ideal for use as a photosensitizer. However, the efficacy of PLP has not yet been evaluated. In this study, the mechanism of cancer cell-specific accumulation of PLP and its cytotoxic effect on cholangiocarcinoma cells were evaluated. The effects were investigated on normal and cancer-like mutant cells. The cytotoxicity effect of PLP PDT in cancer cells was significantly stronger than in normal cells. In addition, reactive oxygen species regulated intracellular PLP accumulation. The cytotoxic effects were also investigated using a cholangiocarcinoma cell line. The cytotoxicity of PLP PDT was significantly higher than that of laserphyrin-based PDT, a conventional type of PDT. PLP PDT could also inhibit tumor growth in vivo.

摘要

在肿瘤的光动力疗法(PDT)中,光敏剂选择性地积聚在癌组织中。在最佳波长的光激发下,光敏剂和周围分子会产生活性氧物种,导致癌细胞特异性细胞毒性。卟啉脂蛋白(PLP)具有基于卟啉的纳米结构。由于其结构,PLP 的卟啉部分被猝灭。当 PLP 被破坏时,堆叠的卟啉被分离成单个分子并充当光敏剂。除非 PLP 被破坏,否则正常组织中不会出现光敏性紊乱。PLP 可以减轻光敏性紊乱,与其他光敏剂相比,它是一种理想的光敏剂。然而,PLP 的疗效尚未得到评估。在这项研究中,评估了 PLP 对胆管癌细胞的癌细胞特异性积累机制及其细胞毒性作用。研究了对正常和类似癌细胞突变体的影响。PLP PDT 在癌细胞中的细胞毒性作用明显强于正常细胞。此外,活性氧调节细胞内 PLP 积累。还使用胆管癌细胞系研究了 PLP PDT 的细胞毒性作用。PLP PDT 的细胞毒性明显高于传统的激光卟啉 PDT。PLP PDT 还可以抑制体内肿瘤生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/465d5304c280/ijms-22-07306-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/32c259ab1f4f/ijms-22-07306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/541b2a15d607/ijms-22-07306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/dc14dc441c71/ijms-22-07306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/7f98db4fce91/ijms-22-07306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/1b6156096d20/ijms-22-07306-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/3811394f67d9/ijms-22-07306-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/a891c4c7d4da/ijms-22-07306-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/465d5304c280/ijms-22-07306-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/32c259ab1f4f/ijms-22-07306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/541b2a15d607/ijms-22-07306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/dc14dc441c71/ijms-22-07306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/7f98db4fce91/ijms-22-07306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/1b6156096d20/ijms-22-07306-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/3811394f67d9/ijms-22-07306-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/a891c4c7d4da/ijms-22-07306-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd60/8305091/465d5304c280/ijms-22-07306-g008.jpg

相似文献

1
Porphylipoprotein Accumulation and Porphylipoprotein Photodynamic Therapy Effects Involving Cancer Cell-Specific Cytotoxicity.卟啉脂蛋白积累和卟啉脂蛋白光动力疗法对癌细胞特异性细胞毒性的影响。
Int J Mol Sci. 2021 Jul 7;22(14):7306. doi: 10.3390/ijms22147306.
2
Cell-Level Analysis Visualizing Photodynamic Therapy with Porphylipoprotein and Talaporphyrin Sodium.细胞水平分析显示叶绿基脂蛋白和他拉泊林钠的光动力疗法。
Int J Mol Sci. 2022 Oct 28;23(21):13140. doi: 10.3390/ijms232113140.
3
A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.一种具有改善的水溶性的下一代双功能光敏剂,用于光动力疗法和诊断。
Oncotarget. 2016 Nov 8;7(45):74259-74268. doi: 10.18632/oncotarget.12366.
4
Synthesis and pharmacological evaluation of chlorin derivatives for photodynamic therapy of cholangiocarcinoma.胆癌光动力治疗用氯代物的合成及药理学评价。
Eur J Med Chem. 2020 Mar 1;189:112049. doi: 10.1016/j.ejmech.2020.112049. Epub 2020 Jan 9.
5
Preparation of a chlorophyll derivative and investigation of its photodynamic activities against cholangiocarcinoma.制备一种叶绿素衍生物,并研究其对胆管癌细胞的光动力活性。
Biomed Pharmacother. 2017 Aug;92:285-292. doi: 10.1016/j.biopha.2017.05.052.
6
Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo.新型氯代卟啉类光动力治疗剂的体外与体内光致敏效果。
J Cancer Res Clin Oncol. 2014 Sep;140(9):1527-36. doi: 10.1007/s00432-014-1717-0. Epub 2014 May 27.
7
Biological Evaluation of Photodynamic Effect Mediated by Nanoparticles with Embedded Porphyrin Photosensitizer.纳米粒子嵌入卟啉类光动力剂介导的光动力效应的生物学评价。
Int J Mol Sci. 2022 Mar 25;23(7):3588. doi: 10.3390/ijms23073588.
8
The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.5,15-二芳基-10,20-二卤代卟啉的光动力学治疗的生物活性。
J Cancer Res Clin Oncol. 2022 Sep;148(9):2335-2346. doi: 10.1007/s00432-022-04037-7. Epub 2022 May 6.
9
Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.铁死亡促进光动力治疗:超分子光敏剂诱导纳米药物增强癌症治疗。
Theranostics. 2019 May 18;9(11):3293-3307. doi: 10.7150/thno.32867. eCollection 2019.
10
The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.顺铂衍生的线粒体活性氧增加通过转运蛋白调节增强光动力疗法的效果。
Cells. 2019 Aug 17;8(8):918. doi: 10.3390/cells8080918.

引用本文的文献

1
Nanostructural and nanomechanical alterations of photosensitized lipid membranes due to light induced formation of reactive oxygen species.由于光诱导活性氧物种的形成导致的光敏脂质膜的纳米结构和纳米力学改变。
Sci Rep. 2025 Jan 2;15(1):110. doi: 10.1038/s41598-024-83758-w.
2
Visualization of Stress Fiber Formation Induced by Photodynamic Therapy with Porphylipoprotein.用卟啉脂蛋白光动力疗法诱导应力纤维形成的可视化
Nanomaterials (Basel). 2024 Nov 21;14(23):1862. doi: 10.3390/nano14231862.
3
Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment.

本文引用的文献

1
Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer.光动力疗法可实现甲状腺癌临床前模型中的肿瘤特异性消融。
Endocr Relat Cancer. 2020 Feb;27(2):41-53. doi: 10.1530/ERC-19-0258.
2
Photodynamic therapy for biliary tract organ via a novel ultra-small composite optical fiberscope.通过新型超小型复合光纤内窥镜对胆道器官进行光动力治疗。
Exp Ther Med. 2017 Nov;14(5):4344-4348. doi: 10.3892/etm.2017.5052. Epub 2017 Aug 28.
3
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.
通过 Purpurin-18-N-Propylimide 甲酯固态脂质纳米粒增强光动力疗法治疗癌症。
Int J Mol Sci. 2024 Sep 26;25(19):10382. doi: 10.3390/ijms251910382.
4
Polphylipoprotein-induced autophagy mechanism with high performance in photodynamic therapy.多聚脂蛋白诱导的自噬机制在光动力疗法中具有优异的性能。
Commun Biol. 2023 Nov 28;6(1):1212. doi: 10.1038/s42003-023-05598-0.
5
Cell-Level Analysis Visualizing Photodynamic Therapy with Porphylipoprotein and Talaporphyrin Sodium.细胞水平分析显示叶绿基脂蛋白和他拉泊林钠的光动力疗法。
Int J Mol Sci. 2022 Oct 28;23(21):13140. doi: 10.3390/ijms232113140.
6
Special Issue: Cellular Oxygen Homeostasis.特刊:细胞氧稳态。
Int J Mol Sci. 2022 Apr 19;23(9):4505. doi: 10.3390/ijms23094505.
肿瘤光动力疗法:基本原理、当前临床现状及未来方向
Cancers (Basel). 2017 Feb 18;9(2):19. doi: 10.3390/cancers9020019.
4
Reactive oxygen species induced by non-steroidal anti-inflammatory drugs enhance the effects of photodynamic therapy in gastric cancer cells.非甾体抗炎药诱导产生的活性氧增强了光动力疗法对胃癌细胞的作用。
J Clin Biochem Nutr. 2016 May;58(3):180-5. doi: 10.3164/jcbn.15-124. Epub 2016 Feb 19.
5
Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage.头颈部癌症的多模态影像引导手术和光动力介入治疗:从原发肿瘤到转移引流。
Clin Cancer Res. 2016 Feb 15;22(4):961-70. doi: 10.1158/1078-0432.CCR-15-1235. Epub 2015 Oct 13.
6
Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.替莫泊芬提高晚期胆道癌光动力治疗的疗效:多中心前瞻性 II 期研究。
Hepatology. 2015 Nov;62(5):1456-65. doi: 10.1002/hep.27905. Epub 2015 Jul 22.
7
A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.无聚乙二醇化仿生卟啉纳米平台用于个性化癌症诊疗。
ACS Nano. 2015;9(4):4484-95. doi: 10.1021/acsnano.5b01077. Epub 2015 Apr 6.
8
Mitochondrial reactive oxygen species accelerate the expression of heme carrier protein 1 and enhance photodynamic cancer therapy effect.线粒体活性氧加速亚铁血红素载体蛋白 1 的表达并增强光动力癌症治疗效果。
J Clin Biochem Nutr. 2014 Jul;55(1):67-71. doi: 10.3164/jcbn.14-27. Epub 2014 Jun 20.
9
Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.光动力疗法的机制:第三部分——光敏剂药代动力学、生物分布、肿瘤定位和肿瘤破坏方式。
Photodiagnosis Photodyn Ther. 2005 Jun;2(2):91-106. doi: 10.1016/S1572-1000(05)00060-8. Epub 2005 Aug 10.
10
Cholangiocarcinoma.胆管癌。
Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26.